Tempus AI is trading at $70.04, up 4.29%, at 10:50 a.m. ET on October 27, 2026; no verified company-specific catalyst or reliable report directly explaining the gain was found.
- The xR assay’s EU IVDR certification was announced October 26, but available coverage does not link it to the move.
- Anthropic’s IPO filing has been cited as lifting broader AI-stock sentiment, but evidence does not establish that it explains Tempus AI’s gain.